Biospective Revenue
Research Services • 
Montreal, Quebec, Canada • 51-100 Employees
Biospective revenue & valuation
| Annual revenue | $5,000,000 |
| Revenue per employee | $93,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues | $16,000,000 |
| Total funding | No funding |
Key Contacts at Biospective
Anna Koshy
Director Of Programs
Joseph Flores
Study Director
Vincent Auclair
Director Of Operations
Elodie Brison
Ph.D., Director, Preclinical Services
Véronik Lachance
Research Scientist/Study Director
Anastasia Noel
Study Director
Kristina Deduck
Associate Director, Preclinical Imaging
Company overview
| Headquarters | 1255 Peel Street, Suite 560, Montreal, Quebec H3B 2T9, CA |
| Phone number | +15143600141 |
| Website | |
| NAICS | 5417 |
| SIC | 873 |
| Keywords | ALS, Multiple Sclerosis, Parkinson’S Disease, Alzheimer’S Disease, Rodent Models, Preclinical Efficacy Studies, Multiple System Atrophy, Early & Late Phase Clinical Trials, Genetic & Rare Diseases, Imaging Core Lab Services, Neuroscience Contract Research Services |
| Founded | 2007 |
| Employees | 51-100 |
| Socials |
Biospective Email Formats
Biospective uses 3 email formats. The most common is {first name} (e.g., john@biospective.com), used 51.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@biospective.com | 51.3% |
{first initial} | j@biospective.com | 46.2% |
{first name}.{last name} | john.doe@biospective.com | 2.6% |
About Biospective
Biospective is a leading Contract Research Organization (CRO) specializing in Neuroscience research studies. We have extensively validated and readily available rodent models of ALS (TDP-43), Alzheimer's disease (beta-amyloid and tau), Parkinson's disease (alpha-synuclein), and multiple sclerosis (EAE and cuprizone) for preclinical research studies. We offer a wide range of preclinical services to evaluate therapeutic agents in these models, including dosing, motor & sensory function, cognition & sleep, electrophysiology, fluid & cellular biomarkers, in vivo imaging (MRI, CT, PET, SPECT), image processing, image analysis, histology, IHC, multiplex immunofluorescence, and spatial biology analysis. Biospective is also a full-service Neuroimaging Core Lab for clinical trials. Our multidisciplinary team provides a comprehensive spectrum of services, including imaging study operations, central eligibility & safety reads, and quantitative image processing & analysis for early through late phase clinical trials. We are the industry leader in quantitative imaging biomarkers derived from multiple modalities, including MRI, PET, and SPECT, for clinical trials of Alzheimer’s disease & tauopathies, Parkinson’s disease & MSA, white matter diseases, and genetic & rare diseases.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Biospective has 34 employees across 7 departments.
Departments
Number of employees
Funding Data
Biospective has never raised funding before.
Biospective Tech Stack
Discover the technologies and tools that power Biospective's digital infrastructure, from frameworks to analytics platforms.
Programming languages
Miscellaneous
Programming languages
Miscellaneous
UI frameworks
CDN
Performance
Webmail
Miscellaneous
Security
JavaScript frameworks
Denmark
United Kingdom
France
United States
Frequently asked questions
4.8
40,000 users
